LNK-010

N/A

Report date: 2025/11/13 10:03:22
NME

Base Information

Drug NameLNK-010
Drug Alias NameLNK-011
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionSignal transducer and activator of transcription 6 degraders
TargetsSignal transducer and activator of transcription 6
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLynk Pharmaceutical (Hangzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLynk Pharmaceutical (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A